Possibility of Non-Immunosuppressive Immunophilin Ligands as Potential Therapeutic Agents for Parkinsons Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
669-677
Author(s):
K. Tanaka and N. Ogawa
(Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) The Role of MDR1 Genetic Polymorphisms in Interindividual Variability in P-glycoprotein Expression and Function
Journal:
Current Drug Metabolism
Volume:
5
Page:
11-19
Author(s):
Erica L. Woodahl and Rodney J.Y. Ho
NSAIDs and Chemoprevention
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
29-42
Author(s):
Chinthalapally V. Rao and Bandaru S. Reddy
Subject index to volume 3
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
107-110
Author(s):
Bentham Science Publishers
Detection of Tumor Markers with ProteinChip® Technology
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
45-67
Author(s):
Andreas Wiesner
Epitope Identification and Discovery Using Phage Display Libraries: Applications in Vaccine Development and Diagnostics
Journal:
Current Drug Targets
Volume:
5
Page:
1-15
Author(s):
Lin-Fa Wang and Meng Yu
Red Blood Cells as Modulators of T Cell Growth and Survival
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
191-201
Author(s):
Fernando A. Arosa, Carlos F. Pereira and Ana M. Fonseca
Antibody-Mediated Endothelial Cell Damage Via Nitric Oxide
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
213-221
Author(s):
Y. S. Lin, C. F. Lin, H. Y. Lei, H. S. Liu, T. M. Yeh, S. H. Chen and C. C. Liu
Angiogenesis: A Target for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
11-26
Author(s):
Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello
The Urokinase Plasminogen Activator System: Role in Malignancy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
39-49
Author(s):
Michael J. Duffy